You are here: Home » News-CM » Companies » News
Business Standard

Glenmark Pharmaceuticals divests its VWash business to Hindustan Unilever

Capital Market 

Glenmark Pharmaceuticals announced that it has entered into an agreement with Hindustan Unilever (HUL) for divestment of its VWash brand and other extensions. Under this agreement, the brand and other trademarks, copyrights, know-how associated with Glenmark's VWash business will be transferred to HUL.

Glenmark will receive an upfront payment and royalty on sales for 3 years. No employees will be transferred as a part of this agreement. The transaction is expected to be completed in the next few months subject to customary approvals.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, March 23 2020. 17:54 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU